Verdad Advisers’s Axogen AXGN Stock Holding History

Verdad Advisers’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,507	Closed	-$381K	–	218
2026 Q1	$381K	Buy	+11,507	New	+$374K	0.43%	82

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Verdad Advisers's AXGN Position: Q2 2026 in Review

Verdad Advisers sold out of Axogen (AXGN) in Q2 2026, closing a stake of 11,507 shares — an estimated $381K sold.

Verdad Advisers first reported a position in AXGN in Q1 2026 and held it in 1 quarter. The position peaked at $381K in Q1 2026. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Verdad Advisers reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
Verdad Advisers sold 11,507 Axogen shares in Q2 2026, an estimated $381K.
Verdad Advisers first reported a position in Axogen in Q1 2026 and held it in 1 quarter.
Verdad Advisers's Axogen position peaked at $381K in Q1 2026.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.